VarmX Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $15.6M

  • Investors
  • 11

VarmX General Information

Description

Manufacturer and developer of therapeutic drugs designed to restore blood clotting in bleeding patients. The company's drugs use modified recombinant human coagulation factor which is capable of restoring blood clotting in the presence of direct factor anticoagulants such as rivaroxaban, apixaban, and edoxaban, enabling physicians to safely and effectively restore hemostasis in case of bleeding.

Contact Information

Website
www.varmx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Emmy Noetherweg 2
  • 2333 BK Leiden
  • Netherlands
+31 06
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Emmy Noetherweg 2
  • 2333 BK Leiden
  • Netherlands
+31 06

VarmX Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VarmX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 26-Feb-2025 $15.6M Completed Clinical Trials - General
7. Later Stage VC (Series B) 25-May-2023 Completed Clinical Trials - General
6. Grant 16-Jun-2021 Completed Clinical Trials - General
5. Early Stage VC (Series B) 03-Jul-2020 Completed Clinical Trials - General
4. Early Stage VC (Series A) 02-Jul-2018 Completed Clinical Trials - General
3. Seed Round 27-Jun-2017 Completed Clinical Trials - General
2. Seed Round 01-Oct-2016 $336K $336K Completed Startup
1. University Spin-Out 01-Jan-2016 Completed Startup
To view VarmX’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

VarmX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VarmX Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sound Bioventures Venture Capital Minority
European Innovation Council Fund Venture Capital Minority
EQT Life Sciences Venture Capital Minority
Inkef Venture Capital Minority
Lundbeckfonden BioCapital Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

VarmX FAQs

  • When was VarmX founded?

    VarmX was founded in 2016.

  • Where is VarmX headquartered?

    VarmX is headquartered in Leiden, Netherlands.

  • What is the size of VarmX?

    VarmX has 20 total employees.

  • What industry is VarmX in?

    VarmX’s primary industry is Drug Discovery.

  • Is VarmX a private or public company?

    VarmX is a Private company.

  • What is VarmX’s current revenue?

    The current revenue for VarmX is .

  • How much funding has VarmX raised over time?

    VarmX has raised $103M.

  • Who are VarmX’s investors?

    Sound Bioventures, European Innovation Council Fund, EQT Life Sciences, Inkef, and Lundbeckfonden BioCapital are 5 of 11 investors who have invested in VarmX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »